Skip to main content
SpringerLink
Log in

Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

We performed a retrospective evaluation of patients with diarrhea-associated hemolytic uremic syndrome (D + HUS) with the aims of: (1) determining the rate of red blood cell (RBC) transfusions; (2) establishing the relationship between need for RBC transfusion and severity of renal involvement; (3) determining whether precise measurements of lactic dehydrogenase (LDH) levels can predict the rate of hemolysis and severity of renal disease.

Methods

A total of 288 patients with D + HUS were retrospectively divided into three groups based on dialysis treatment: group 1, no dialysis treatment (144 patients); group 2, dialysis for 1–10 days (67 patients); group 3, dialysis for ≥11 days (77 patients).

Results

Of the patients in groups 1, 2 and 3, 73.6, 86.5 and 83.1 %, respectively, required at least one RBC transfusion. The number of RBC transfusions in groups 1, 2 and 3 was 163, 107 and 162, respectively. Comparison of the groups revealed that the number of RBC transfusions was significantly higher in patients in groups 2 and 3 than in those in group 1 (p = 0.0001). Most RBC transfusions (94.2 %) occurred during the first 2 weeks of the disease. The median peak LDH level was 2091 U/l in 32 patients with no RBC transfusion (group A), 3900 U/l in 73 patients with one transfusion (group B) and 6378 U/l in 62 patients with two or more transfusions (group C). Patients who received two or more RBC transfusions had a significantly higher median peak LDH level than those who did not receive RBC transfusions or received only one transfusion. This difference was also observed between patients who received only one RBC transfusion and those who did not receive any transfusions (p < 0.00001). Comparison of LDH levels on admission and peak LDH levels among patients in groups A, B and C revealed that 28/32 patients in group A, 56/73 patients in group B and 33/62 patients in group C had a stable LDH level, suggesting that patients with a stable LDH level require fewer RBC transfusions (p ≤ 0.006). Finally, we evaluated the possibility of an association between peak LDH levels and the degree of renal disease. The median peak LDH level in patients of group 1, 2 and 3 was 3538 (range 756–9373), 5165 (451–9205) and 7510 (1,145–16,340) U/l, respectively. Patients with >10 days of dialysis (group 3) had the highest LDH levels, followed by patients with 1–10 days of dialysis (group 2) and then by patients with no dialysis requirements (group 1) (p < 0.00001).

Conclusions

The rate of RBC transfusion was higher in patients with the most severe renal injury, and most were performed during the first 2 weeks of the disease. Patients with stable LDH levels seemed to require fewer RBC transfusions. Median peak LDH levels were significantly higher in the group of patients with the most severe renal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Novillo AA, Voyer LE, Craviotto R, Freire MC, Castaño C, Wainstein R, Binztein N (1988) Hemolytic uremic syndrome associated with faecal cytotoxin and verotoxin neutralizing antibodies. Pediatr Nephrol 2:288–290

    Article  CAS  PubMed  Google Scholar 

  2. Gianantonio C, Vitacco M, Mendilaharzu F, Rutti A, Mendilaharzu J (1964) The haemolytic uremic syndrome. J Pediatr 64:478–491

    Article  CAS  PubMed  Google Scholar 

  3. Johnson S, Taylor CM (2009) Hemolytic uremic syndrome. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N (eds) Pediatric Nephrology, 6th edn. Springer, Berlin, Heidelberg, pp 1155–1180

    Chapter  Google Scholar 

  4. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso J, Amoreo O (1997) Childhood hemolytic uremic syndrome in Argentina. Long-term follow up and prognostic features. Pediatr Nephrol 11:156–160

    Article  CAS  PubMed  Google Scholar 

  5. Cobeñas CJ, Alconcher LF, Spizzirri AP, Rahman RC (2007) Long-term follow up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis. Pediatr Nephrol 22:1343–1347

    Article  PubMed  Google Scholar 

  6. Rahman RC, Cobeñas CJ, Drut R, Amoreo OR, Ruscasso JD, Spizzirri AP, Suárez AC, Zalba JH, Ferrari C, Gatti MC (2012) Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 27:229–233

    Article  PubMed  Google Scholar 

  7. Meyers KEC, Kaplan BS (1999) Hemolytic-uremic syndromes. In: Barratt TM, Avner ED, Harmon WE (eds) Paediatric Nephrology, 4th edn. Lippincott, Williams & Wilkins, pp 811–822

    Google Scholar 

  8. Epidat 4.1 para Windows (2014). Análisis Epidemiológico de Datos Tabulados. Programa desarrollado por la Xunta de Galicia y la Organización Panamericana de la Salud. Available at:http://www.sergas.es/MostrarContidos_N3_T01.aspx?IdPaxina=62713. Last accessed 10 Apr 2015

  9. Di Rienzo JA, Casanoves F, Balzarini MG, Gonzalez L, Tablada M, Robledo CW (2014) InfoStat versión 2014. Grupo InfoStat, FCA, Universidad Nacional de Córdoba, Argentina. Available at: http://www.infostat.com.ar. Last accessed 10 Apr 2015

  10. Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H (1990) Hemolytic uremic syndromes in the British Isles 1995–8: association with verocytotoxin producing Escherichia coli. Part I: clinical and epidemiological aspects. Arch Dis Child 65(7):716–721

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Repetto HA (1997) Epidemic hemolytic-uremic syndrome in children. Kidney Int 52:1708–1719

    Article  CAS  PubMed  Google Scholar 

  12. Repetto HA (2005) Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome. Kidney Int 58[Suppl 97]:S102–S106

    Article  Google Scholar 

  13. Exeni R, Donato H, Rendo P, Antonuccio M, Rapetti MC, Grimoldi I, Exeni A, de Galvagni A, Trepacka E, Amore A (1998) Low levels of serum erythropoietin in children with endemic hemolytic uremic syndrome. Pediatr Nephrol 12:226–230

    Article  CAS  PubMed  Google Scholar 

  14. Pape L, Ahlenstiel T, Kreuzer M, Drube J, Froede K, Franke D, Ehrich JH, Haubitz M (2009) Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial. Pediatr Nephrol 24:1061–1064

    Article  PubMed  Google Scholar 

  15. Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2015) Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case control study. Pediatr Nephrol 30:339–344

    Article  PubMed  Google Scholar 

  16. Cohen L, Djordjevich J, Ormiste V (1964) Known lactic dehydrogenase isoenzyme patterns in cardiovascular and other diseases, with particular reference to acute myocardial infarction. J Lab Clin Med 64:355–374

    CAS  PubMed  Google Scholar 

  17. Lechi A, Rizzotti P, Mengioli C, Arosio E, Pancera P (1983) Lactic dehydrogenase isoenzyme in urinary tract infections and aminoglycoside nephrotoxicity. Infection 11:52–53

    Article  CAS  PubMed  Google Scholar 

  18. Fredericks M, Dworkin R, Ward D, Steiner R (1986) Antibiotic-induced acute renal failure associated with elevated serum lactic dehydrogenase level of renal origin. West J Med 144:743–744

    PubMed Central  CAS  PubMed  Google Scholar 

  19. Lyon AW, Chin AC, Slotsve GA, Lyon ME (2013) Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model. Comput Biol Med 43:84–90

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Mrs Paula Risso for the statistical support.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Hospital de Niños “Sup. Sor María Ludovica”, La Plata, Buenos Aires, Argentina

    Carlos J. Cobeñas, Paula S. Bresso, Laura L. Lombardi, Oscar R. Amoreo, Javier D. Ruscasso, Ana P. Spizzirri, Ângela del C. Suarez, Javier H. Zalba & Ricardo C. Rahman

  2. Cátedra de Bioestadística Bayesiana y Clásica, Carrera de Microbiología Clínica e Industrial, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina

    Paula Risso

Authors
  1. Carlos J. Cobeñas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula S. Bresso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura L. Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oscar R. Amoreo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Javier D. Ruscasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana P. Spizzirri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ângela del C. Suarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Javier H. Zalba
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ricardo C. Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Paula Risso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos J. Cobeñas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cobeñas, C.J., Bresso, P.S., Lombardi, L.L. et al. Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome. Pediatr Nephrol 30, 2115–2119 (2015). https://doi.org/10.1007/s00467-015-3147-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-015-3147-x

Keywords

Search

Navigation